Omada Health, a virtual-first healthcare provider, announced a specialized program enhancement for members taking GLP-1s, in response to the growing interest and demand for the medication.
Read Article
In recent years, diabetes has been on the rise worldwide, causing what’s known as the global "diabetes epidemic." In the U.S., alone, we’ve seen diabetes have significant health and economic consequen
Read Article
Delivering impactful health improvements takes more than standard caregiving. Think about the one medical check-up you have per year: data collected at a single appointment can’t capture...
Read Article
Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.
Read Resource
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
Error - something went wrong!
Subscribe to the Omada Insider monthly newsletter for thought leadership, industry insights and the newest happenings
Thank you!
Lisa McCormick, FNP-BC, RD, CDCES explores the science behind dieting and why it doesn't work. Find out more about sustainable weight loss!
Read Article
Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes
Read Article
Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.
Read Article
Obesity is now widely recognized as a lifelong chronic disease–but what’s behind that evolution? Join us to find out!
Read Article
Join Us at HLTH 2024 in Las Vegas!
Read Article
Pioneering Transformation at AHIP 2024 Consumer Experience and Digital Health Forum
Read Article
Omada Health: Shining as a Gold Level Sponsor at AHIP 2024!
Read Article
Omada delivers GLP-1 FAQs focusing on weight loss quantity vs. quality with timely data and insights for employers, health plans and benefit consultants.
Read Article
Building on more than a decade of insights and 28 peer-reviewed publications, Omada announces plans to develop more learnings focused on the long-term outcomes of GLP-1s on weight health
Read Article
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support.
Read Article
The purpose of this study is to examine the long-term impact of a digital diabetes self-management education and support (DSMES) program on A1C among adults with type 2 diabetes (T2DM).
Read Article
Obesity is one of the clearest case studies of health disparities that exist in the U.S., having the biggest impact on Black and Hispanic adults, low-income populations, and people covered by Medicaid
Read Article
Digital health is rapidly growing and promises to make healthcare more accessible and convenient for patients. However, not all digital healthcare providers are created equally.
Read Article
Analysis shows GLP-1s are twice as effective with lifestyle support programs. Download this free report by Omada Health and Express Scripts to learn more.
Read Resource
Omada Health Customer Case Study: Learn how Essentia Health surpassed enrollment and engagement goals in its diabetes programs, and how they market virtual care solutions to their population.
Read Article
Loading More...
